Synthetic Biology Milestone: StrainX Bioworks Emerges from Stealth with $13M Round Co-Led by Leo Capital and Prime Venture Partners
What is the news?
Indian deep-tech and precision fermentation innovator, StrainX Bioworks, has officially announced its emergence from stealth mode, backed by a significant $13 million investment round. Co-led by prominent venture capital firms Leo Capital and Prime Venture Partners, the funding marks a major milestone for the alternative protein and synthetic biology landscape in the region. The round also saw notable participation from international and domestic institutional investors, including Good Startup, Sparrow Capital, Sun Icon Ventures, Dholakia Ventures, and the IIT Delhi alumnus fund, WindT Angels.
Why is it interesting?
Co-founded by IIT Delhi alumni Akshay Mittal (CEO) and Alok Malaviya (CTO), StrainX Bioworks utilizes advanced synthetic biology and precision fermentation techniques to engineer high-value food and nutritional ingredients. The platform has been uniquely built to develop multiple complex molecules over time, initially targeting the rapidly growing global demand for sustainable alternative proteins. Striking a rare balance between deep-tech research and rapid execution, the three-year-old startup already commands an operational team of over 100 professionals and runs an expansive manufacturing facility in Bhopal equipped with a 10,000-litre fermentation capacity.
Crucially, StrainX is positioning itself as a key supplier for the international B2B corridor. The startup has already self-affirmed its initial precision-fermented molecule under the United States Food and Drug Administration’s (FDA) strict Generally Recognized as Safe (GRAS) provisions, laying immediate groundwork to partner with global food, beverage, and ingredient conglomerates. By marrying top-tier domestic intellectual capital with structural commercial scalability, StrainX showcases the rising capability of the Indian founders community to anchor global climate and food-tech infrastructure.
Read more: StrainX Bioworks raises $13 Mn led by Prime Venture Partners and Leo Capital
